Orphapacket:
  ORPHApacketId: '370334'
  creationDate: '2020-12-03 15:53:15'
  version: 1.3.6 / 4.1.7 [2020-04-17] (orientdb version)
  copyright: Orphanet (c) 2020
  ORPHAcode: '370334'
  Label: Extraskeletal Ewing sarcoma
  PURL: http://www.orpha.net/ORDO/Orphanet_370334
  DisorderType:
    value: Disease
    PURL: http://www.orpha.net/ORDO/Orphanet_377788
  Synonyms:
  - Synonym: EOE
  - Synonym: Extraosseous Ewing sarcoma
  - Synonym: Extraosseous Ewing tumor
  - Synonym: Extraskeletal Ewing tumor
  TextSection:
    TextSectionType: Definition
    Contents: 'Extraskeletal Ewing sarcoma is a rare poorly differentiated highly
      malignant soft tissue tumor derived from neuroectoderm that is morphologically
      indistinguishable from skeletal Ewing sarcoma but is located in extraosseous
      locations with the most common being: chest wall paravertebral region abdominopelvic
      area (with predilection for the retroperitoneal space) gluteal region and lower
      extremities. Clinical presentation is highly variable and depends on tumor localization.
      Local recurrence is common and metastatic disease most frequently involves the
      bones and lungs.'
  Genes:
  - Gene:
      Symbol: ERG
      Name: ETS transcription factor ERG
      ExternalReferences: []
  - Gene:
      Symbol: EWSR1
      Name: EWS RNA binding protein 1
      ExternalReferences: []
  - Gene:
      Symbol: FLI1
      Name: Fli-1 proto-oncogene, ETS transcription factor
      ExternalReferences: []
  - Gene:
      Symbol: SMARCA5
      Name: SWI/SNF related, matrix associated, actin dependent regulator of chromatin,
        subfamily a, member 5
      ExternalReferences: []
  Parents:
  - Parent:
    - ORPHAcode: '3394'
      Label: Soft tissue sarcoma
  - Parent:
    - ORPHAcode: '506219'
      Label: Rare disorder potentially indicated for hematopoietic stem cell transplant
  Prevalences:
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Austria
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Belgium
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Bulgaria
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Croatia
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Czech Republic
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Estonia
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Germany
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Ireland
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Italy
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Latvia
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Lithuania
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Norway
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Poland
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Portugal
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Slovenia
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Spain
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Switzerland
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Netherlands
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: United Kingdom
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Finland
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Malta
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Slovakia
  AverageAgeOfOnsets:
  - AverageAgeOfOnset:
      value: Adolescent
  - AverageAgeOfOnset:
      value: Adult
  - AverageAgeOfOnset:
      value: Childhood
